Idxg stock.

Interpace Biosciences Inc (OTC:IDXG) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more ...The estimated Net Worth of Thomas W. Burnell is at least $435 Thousand dollars as of 21 May 2021. Dr Burnell owns over 10,855 units of Interpace Biosciences Inc stock worth over $10,204 and over the last 3 years he sold IDXG stock worth over $0. In addition, he makes $425,004 as Pres and CEO & Director at Interpace Biosciences Inc.Dec 1, 2023 · Shareholders Equity (Quarterly) is a widely used stock evaluation measure. Find the latest Shareholders Equity (Quarterly) for Interpace Biosciences (IDXG) Interpace Biosciences Inc stock is down 4.75% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator. Interpace Biosciences Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on IDXG!

Jack E. Stover. Employees: 90. MORRIS CORPORATE CENTER 1,, BUILDING C, 300 INTERPACE PARKWAY, PARSIPPANY, NJ 07054. 412-224-6100. interpace.com. • *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know. Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics ...Discover the top 3 undervalued Managed Health care stocks for Monday, November 20 based on AAII’s Stock Grades. Eunice Kim. Stock Grade Focus Is Interpace Biosciences Inc (IDXG) Stock a Good Investment?Get the latest news and real-time alerts from Interpace Biosciences, Inc. (IDXG) stock at Seeking Alpha.

IDXG stock fares better after Case 1, with a 39.2% chance of rise over the next month (21 trading days) under Case 1 (where the stock has suffered a 5% loss over the previous month), versus, a 34.9% chance of rise for Case 2. This would suggest that it is better to buy IDXG stock after a recent drop

Interpace Biosciences on Wednesday said it had closed the sale of its pharma services business to Flagship Biosciences.IDXG CEO Thomas Burnell said with the completion of the deal, the company's ...Jul 26, 2023 1:47 PM EDT | Currency in USD Overview Key Ratios Trading Information Last Close 1.96 Sector Healthcare Industry Diagnostics & Research …Gorman Robert J. - PDII / PDI, Inc. - Insider Trade Report6201 15th Avenue. Brooklyn, NY 11219. T: 718-921-8300. [email protected]. www.astfinancial.com. Interpace Biosciences® is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer. Interpace Biosciences is a fully integrated commercial and ...

Find the latest Research Frontiers Incorporated (REFR) stock quote, history, news and other vital information to help you with your stock trading and investing.

The Company announces the complete sale of the pharma services business which could impact the IDXG Stock . For more information regarding the Company's business, visit OTC Wiki. Interpace Biosciences Inc is a leading company that specializes in enabling personalized medicinal products. This Company has closed a definitive asset …

Interpace Biosciences Inc (IDXG) stock is down -31.64% while the S&P 500 is up 0.35% as of 2:31 PM on Monday, Aug 17. IDXG is down -$1.83 from the previous closing price of $5.78 on volume of 968,030 shares. Over the past year the S&P 500 has risen 15.77% while IDXG is down -47.33%. IDXG lost -$8.53 per share the over the last 12 months.Shareholders Equity (Quarterly) is a widely used stock evaluation measure. Find the latest Shareholders Equity (Quarterly) for Interpace Biosciences (IDXG)Analyst Sentiment - World. United States Canada UK Hong Kong Japan Australia New Zealand. Germany Switzerland Spain Poland Netherlands Greece France Ireland Italy Belgium Austria Israel TürkiyeIt operates under one segment which is the business of developing and selling diagnostic clinical services. In depth view into IDXG (Interpace Biosciences) stock including the latest price, news, dividend history, earnings information and financials.What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...

Oct 14, 2020 · IDXG stock has continued to hover around that price until today’s news gave it a shot in the arm. IDXG stock was up 47.7% as of Wednesday afternoon. On the date of publication, William White did ... 6201 15th Avenue. Brooklyn, NY 11219. T: 718-921-8300. [email protected]. www.astfinancial.com. Interpace Biosciences® is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer. Interpace Biosciences is a fully integrated commercial and ...Interpace Biosciences Inc. (IDXG) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.OTCPK:IDXG Stock Report. Mkt Cap: US$5.4m. Add to watchlist. Company Overview; 1 Valuation; 2 Future Growth; 3 Past Performance; 4 Financial Health; 5 Dividend; 6 Management; 7 Ownership; ... IDXG). Sep 01. Interpace Biosciences, Inc. Announces New Clinical Validation Data for Thyroid Cancer Test Platform Published Online Within …

Find the latest Accelerate Diagnostics, Inc. (AXDX) stock quote, history, news and other vital information to help you with your stock trading and investing.LKNCY Stock. Located in the Cayman Islands, Luckin Coffee Inc. (OTC: LKNCY, STU: LC0A) is a holding company that provides retail services for freshly brewed coffee and other beverages. It conducts business in the People's Republic of China.

A high-level overview of Interpace Biosciences, Inc. (IDXG) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Part of Company’s Site Consolidation and Cost Savings Measures . Parsippany, NJ, March 17, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTC: IDXG) announced today that it has entered into a definitive agreement to sell its New Haven CT CLIA certified, CAP accredited laboratory to DiamiR Biosciences, Corp. …WalletInvestor is an investment research platform designed to help users find profitable trading opportunities. This platform covers more than 100,000 assets, including stocks, ETFs, forex, cryptocurrencies, and commodities. WalletInvestor offers 7-day, 3-month, 1-year, and 5-year price targets for each asset using a machine learning algorithm.Track Ideanomics Inc (IDEX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors. Join the Conversation! Build your trading network; Follow your favorite assets ...Aug. 18, 2020 11:52 AM ET Clovis Oncology, Inc. (CLVSQ) IDXG, MYOV 7 Comments 3 Likes. Avisol Capital Partners. Investing Group Leader. ... I/we have no positions in any stocks mentioned, ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.IDXG Message Board Parsippany, NJ, April 22, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG ) today issued the following statement. Interpace continues to make progress executing its growth strategy and the Company recently increased 2021 revenue guidance.Stock Symbol NASDAQ:IDXG. Funding Rounds 1. Total Funding Amount $3.9M. Total Funding Amount . Unlock for free . Funding. Interpace Biosciences has raised a total of . $3.9M. in funding over 1 round. This was a Post-IPO Equity round raised on Feb 8, 2017. Interpace Biosciences is registered under the ticker NASDAQ:IDXG .

Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...

David Kerr Senior VP Business Development at Interpace Diagnostics Group, is currently unranked, see this insider's latest transactions.

MiMedx Group (MDXG, $7.57) RSI Indicator left the overbought zone on November 22, 2023. Track Mimedx Group Inc (MDXG) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.The estimated Net Worth of Thomas W. Burnell is at least $437 millier dollars as of 21 May 2021. Dr Burnell owns over 10,855 units of Interpace Biosciences Inc stock worth over $12,158 and over the last 3 years he sold IDXG stock worth over $0. In addition, he makes $425,004 as Pres et CEO & Director at Interpace Biosciences Inc.MiMedx Group (MDXG, $7.57) RSI Indicator left the overbought zone on November 22, 2023. Track Mimedx Group Inc (MDXG) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.U.S. Stock Market Overview Top Analyst Stocks Top Smart Score Stocks Top Insiders Stocks. Popular. Stock Screener Top Online Growth Stocks. New. Trending Stocks Penny Stock Screener. Dividend Investing. Dividend Calculator Dividend Yield Calculator. New. Dividend Stocks Dividend News Dividend Calendar.95.34. -1.33%. 1.33M. Get details on the Hospira stock dividend history and find the HSP ex-dividend date.Get the latest OTC Markets Group Inc (OTCM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Parsippany, NJ, March 11, 2020 (GLOBE NEWSWIRE) -- Interpace Diagnostics, a subsidiary of Interpace Biosciences (NASDAQ: IDXG) announced today that it has entered into a contract with Blue Cross Blue Shield of Massachusetts.While terms of this Agreement are not disclosed, Interpace is an in-network lab with Blue Cross Blue Shield of …IDXG Stock Return DVA Stock Return ... We favor stocks that offer meaningfully greater expected return in the next 3 years; These returns are calculated based on our revenue forecast and Price to Sales Ratio (P/S) scenarios considered; Similar Price To Sales Ratio (P/S) scenarios are considered for both stocks and each scenario is weighted ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Interpace Biosciences Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The median estimate represents a +909.17% increase from the last price of 1.09. Chart unavailable.

MiMedx Group (MDXG, $7.57) RSI Indicator left the overbought zone on November 22, 2023. Track Mimedx Group Inc (MDXG) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.Oct 16, 2023 · Interpace Biosciences GAAP EPS of -$0.53, revenue of $10.38M. SA NewsMon, May 16, 2022 1 Comment. IDXG Earnings Date and Information. Interpace Biosciences last issued its earnings results on November 8th, 2023. The business services provider reported ($0.12) EPS for the quarter. The business had revenue of $9.08 million for the quarter.Interpace Biosciences Inc stock is down 4.75% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator. Interpace Biosciences Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on IDXG!Instagram:https://instagram. crypto.com newsstock ungstp forex brokersbest python course on udemy Today's Market. A high-level overview of Interpace Biosciences, Inc. (IDXG) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, …EPS forecast (this quarter) $0.11. Annual revenue (last year) $31.8M. Annual profit (last year) -$22.0M. Net profit margin. -18.42%. nasdaq txnbe stocks Interpace Biosciences Completes Sale of Its Pharma Services Business to Flagship Biosciences, Inc. PARSIPPANY, NJ, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, has announced the closing of a d... 1 year ago - GlobeNewsWire.On average, Interpace Biosciences Inc executives and independent directors trade stock every 99 days with the average trade being worth of $29,732. The most recent stock trade was executed by Thomas W. Burnell on 21 May 2021, trading 10,855 units of IDXG stock currently worth $94,221. spy stock charts A solid price increase over a period of 12 weeks reflects investors' continued willingness to pay more for the potential upside in a stock. IDXG is quite a good fit in this regard, gaining 42.5% ...Stock Price Statistics The stock price has decreased by -30.00% in the last 52 weeks. The beta is 0.64, so IDXG's price volatility has been lower than the market average.